As the October 17 deadline looms, what is the state of provincial reform in Canada and who stands to have the most influence in local markets?
As the October 17 deadline looms, what is the state of provincial reform in Canada and who stands to have the most influence in local markets?
GW Pharmaceuticals’ eye-watering price tag for its new CBD drug might fly (temporarily) in the U.S., but in Europe, competition is being encouraged.
Better understanding of cannabis-related photobiology is helping LED grow light manufacturers produce lighting that increases crop yields and perhaps more importantly, cannabis quality.
A step-by-step guide to evaluating potential suppliers of packaging, active ingredients and excipients for cannabis-infused products.
This article will help businesses better understand the distillation chemistry used to produce a cannabis distillate product.
Europe’s cannabis reforms and market opening might be all the rage right now in the mainstream global industry, but what about the jolly green cannabis giant, China?
It is hardly an “October Surprise” that global markets are starting to align on timing issues – but what does this odd situation herald for the burgeoning international industry?
With an entire track dedicated to cannabis this year, attendees will learn about a range of critical issues connecting cannabis and food safety, from product safety to quality in edibles manufacturing to regulations and standards.
Europe has seen major developments this quarter, promising a busy third quarter in Germany, the United Kingdom, and of course, Canada
Cannabis-infused product manufacturers can follow three process validation stages to ensure consistency and reproducibility.